Radiation before Chemo-Immunotherapy shows promise in advanced lung cancer
NCT ID NCT05440916
First seen Dec 16, 2025 · Last updated May 14, 2026 · Updated 26 times
Summary
This study looked at whether giving palliative radiation to 2 to 5 tumor sites before starting standard immunotherapy and chemotherapy can help people with advanced non-small cell lung cancer. Fifty adults with stage IV cancer and low PD-L1 levels took part. The goal was to see if this approach delays cancer growth or improves survival compared to standard treatment alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
-
University Clinic Golnik
Golnik, 4204, Slovenia
-
University Medical Centre Maribor
Maribor, 2000, Slovenia
Conditions
Explore the condition pages connected to this study.